APW
NVO

Aurora Private Wealth’s Novo Nordisk NVO Stock Holding History

Aurora Private Wealth’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,883
Closed -$350K – 185
2026
Q1 		$350K Hold
6,883
– – 0.25% 102
2025
Q4 		$350K Buy
+6,883
New +$352K 0.23% 103
2024
Q4 		– Sell
-2,023
Closed -$241K – 165
2024
Q3 		$241K Sell
2,023
-30
-1% -$4K 0.19% 130
2024
Q2 		$293K Buy
2,053
+218
+12% +$28.9K 0.26% 100
2024
Q1 		$234K Buy
+1,835
New +$218K 0.2% 134

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
GIM
Generate Investment Management Auckland, New Zealand $2.43B AUM 37.24% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

Aurora Private Wealth's NVO Position: Q2 2026 in Review

Aurora Private Wealth sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 6,883 shares — an estimated $350K sold.

Aurora Private Wealth first reported a position in NVO in Q1 2024 and held it in 5 quarters. The position peaked at $350K in Q1 2026. 444 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Aurora Private Wealth reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • Aurora Private Wealth sold 6,883 Novo Nordisk shares in Q2 2026, an estimated $350K.
  • Aurora Private Wealth first reported a position in Novo Nordisk in Q1 2024 and held it in 5 quarters.
  • Aurora Private Wealth's Novo Nordisk position peaked at $350K in Q1 2026.
  • 444 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Aurora Private Wealth's 13F filing for Q2 2026, filed 22 Jul 2026.